We would usually look for evidence for the mechanism of action (how treatment works on a molecular or cellular basis), as well as efficacy, in humans before pursuing HTA research on a particular treatment.
scorpion wrote:After reading the article it seems the trial was declined because the science behind CCSVI is not sound enough for the investigators.
MarkW wrote:MarkW wrote: To get this body to undertake research it would need a lot of background and some serious lobbying. I have not seen these going on in the UK.
Users browsing this forum: No registered users